Head of Department:

Dr. Laxman Pandey MBBS, MD (Radiotherapy)

Dr. Laxman Pandey
(MBBS, MD (Radiotherapy) )

Rohilkhand Cancer Institute is one of the Premiere centres of radiation oncology established in the city of Bareilly, Uttar Pradesh, India. The institute was started with the intention of providing patients with State-of-the-art radiotherapy facilities of international standards with comprehensive cancer care at affordable, nominal charges. Radiotherapy is a highly effective form of cancer treatment with a wide range of uses and applications. Radiation therapy helps to completely cure cancer either as a single modality or along with other treatments for relieving symptoms or extending the overall survival in patients with highly advanced or metastatic cancers. Radiation therapy targets the affected area with high-energy beams, often to the location of the tumour or the area where a tumour was removed after surgery to destroy any remaining microscopic cancer cells. Radiotherapy contributes to cancer cures worldwide as well as improving the quality of life for many others.

Our Team

Dr. Laxman Pandey
MBBS, MD (Radiotherapy)

Dr. Laxman Pandey is a Consultant Radiation Oncologist and completed his MD Radiotherapy from Sarojini Naidu Medical College Agra in 2017. He has five years of experience and counting in radiotherapy in various institutes including the MMIMSR Ambala, AIIMS -Rishikesh, and SRMS Bareilly. His clinical expertise is Conformal radiation therapy (SRT/SBRT/IGRT/IMRT/VMAT), Brachytherapy, Chemotherapy for solid tumours and Palliative care. Currently, he is associated with Rohilkhand Cancer Institute Bareilly as Assistant Professor and Head- Department of Radiation Oncology. He is also an active member of the Association of Radiation Oncologists of India (AROI), and the European Society for Medical Oncology (ESMO) and had valuable publications in both national and international journals.

Dr. Laxman Pandey – Research And Publication

1: Joseph D, Pandey L, Pasricha R, Raut S, Yanpothung Y, Ibrahim A, et al. Stage migration in head and neck cancers due to extranodal extension: Clinical experience from a tertiary care centre. J Med Evid 2021. More.

2: Pandey, R. Pasricha, D. Joseph et al., Use of complementary and alternative medicine among patients with cancer in a sub-Himalayan state in India: An exploratory study. Journal of Ayurveda and Integrative Medicine 12 (2021) 126-130. More.

3: Inampudi P, Seam RK, Pandey L, Malik D, Pandey A, Anjali A, et al. 84P Prospective comparative study of dosimetric parameters and acute radiation toxicity of 3-dimensional conformal radiotherapy (3DCRT) and volumetric modulated arc therapy (VMAT) in post-mastectomy carcinoma breast patients. Ann Oncol. 2021;32: S57 More.

4: A. Pandey, R.K. Seam, L. Pandey, D. Malik, R. Mahajan, et al. Adaptive radiotherapy in head and neck cancer: A prospective dominatrices and volumetric study. Ann Oncol. 202;32: S794 More.

Dr. Vishwadeep Mishra

Professional Journey

  • MBBS, MD (Radiation Oncology)
  • Ex Academic Senior Resident, SRMS IMS Bareilly, Uttar Pradesh
  • Ex Academic Senior Resident, SGPGI, Lucknow, Uttar Pradesh
  • Ex Academic  Senior Resident, Tata Memorial Center (MPMMCC & HBCH), Varanasi, Uttar Pradesh
  • Assistant Professor (Dept. Of Radiation Oncology) at Rohilkhand Cancer Hospital, Bareilly, Uttar Pradesh


Clinical experience:

  • About 3 years of experience in the field of Radiation Oncology (Post MD) practising all Radiotherapy techniques like conventional, 3DCRT, IMRT and IGRT in almost all cancer sites
  • Total 8 years of experience in the field of Oncology.

Teaching Experience:

  • As a Senior Resident, active participation in the teaching programme of junior residents.
  • Seminar Presentations in Teaching Curriculum

        Area of Interest:

  • EBRT Planning: In various sites like Head and neck, Breast, Gynaecological Malignancies, Urinary Bladder, Prostate, Brain, Esophagus and Bone Tumors.
  • Brachytherapy Planning: Experience in intracavitary radiotherapy, interstitial and intraluminal radiotherapy.
  • Chemotherapy & Targeted Therapy  Administration: For all solid tumours.  


  • Best Paper award in  Senior Resident Category UPAROICON 
  • Second Prize in Onco Quiz in v ONCO update (#VIII- Multidisciplinary Approach)

        Ongoing Research:

  • A Retrospective Analysis of Wilms Tumor Patients Treated with Multimodality Approach Treated in a Tertiary Care Centre.
  • A Retrospective Analysis of Ewing Sarcoma Patients Treated with a Multi-modality Approach Treated in a Tertiary Care Center.
  • Service evaluation in GBM treated by surgery and chemo-radiotherapy from 2013 to 2019.
  • Retrospective analysis of patients of CA Anal canal treated by chemoradiation to evaluate outcomes.

Dr. Siddharth Arora

Dr. Siddharth Arora completed his bachelor’s from the prestigious Sri Devaraj urs Academy Kolar Karnataka. He went on to do a diplomate in the national board in radiation oncology from Yashoda Hospitals Hyderabad. Following he completed his fellowship in Clinical Oncology from Tata medical centre Kolkata. Further at Tata Hospital Sangrur he continued as a senior resident. He has joined Rohilkhand Medical College in the Department of Radiation Oncology.

Professional membership AROI
European counsel of medical oncology
Cleared ESMO examination

Special interests include head and neck cancers, oral cancers, brain tumours, cervical cancer, uterine cancer, prostate cancer, lung cancer, breast cancer, bladder cancer, oesophagal cancer and pancreatic cancer.


Prioritizing delivery of cancer treatment during a COVID-19 lockdown- the experience of a clinical oncology service in India, JCO Global Oncology 2021

Our Services

3 Dimensional Conformal Radiation Therapy (3DCRT)

Intensity Modulated Radiation Therapy and Volumetric Modulated Radiation Therapy (IMRT & VMAT)

Stereotactic Radiosurgery & Stereotactic Body Radiation Therapy (SRS & SBRT)

Image Guided Radiation Treatment (IGRT)

Respiratory Gating

Total Skin Electron Radiation Therapy (TSET)


True Beam

Deliver precise dosage quickly and give patients their time back—the True Beam® radiotherapy system is built with human needs in mind. Designed to treat cancer wherever it’s found in the body, it’s flexible enough to meet your clinical needs as well.

TrueBeam High-precision cancer treatment


User-centered design makes it easier to perform treatment—and let you focus more energy on your patients..


Facilitates innovation and collaboration that results in new treatment options for patients, new opportunities for clinics, and new advances in the fight against cancer.


User-centered design makes it easier to perform treatment—and let you focus more energy on your patients.

Enquiry Form